Overview
Meixia Chen practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Primary Mediastinal B-Cell Lymphoma (PMBCL), and Mediastinal Tumor.
They are actively involved in clinical research, co-authoring 25 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Meixia Chen
Is Meixia Chen a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Meixia Chen is classified as an Experienced expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Meixia Chen participate in research or clinical trials?
Yes. Meixia Chen has published 25 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Meixia Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Classical Hodgkin LymphomaChen isExperienced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaChen isExperienced. Learn about Hodgkin Lymphoma.
- Mediastinal TumorChen isExperienced. Learn about Mediastinal Tumor.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)